logo
  Join        Login             Stock Quote

DaVita (DVA) Kidney Care Division In Drug Services Contract With Fresenius Medical Care

 January 08, 2013 01:51 PM
 


(By Balachander) DaVita HealthCare Partners Inc. (NYSE: DVA) said its kidney care division has agreed to provide certain pharmacy services to Fresenius Medical Care (FMC).

FMC, which offers dialysis services, will use DaVita Rx prescription drug services for its Medicare patients in the United States.

Congress required that beginning in 2011, some oral medications will be included in the bundled payment model. By 2016 all oral end stage renal disease medications will be included in the bundled payment.

FMC's contract with DaVita Rx will help implement that requirement by using DaVita Rx's pharmacy to fill and ship oral medications to FMC Medicare patients.

[Related -Japan Surges Near 5-Year Highs]

DaVita Rx pharmacy services for FMC will begin in late 2013.

In addition, DaVita said it will be extending its long-standing vendor relationship with FMC for certain dialysis supplies including hemodialysis machines and disposable products.

DaVita Rx has served the prescription drug needs of patients receiving dialysis from DaVita and other dialysis providers since 2005.

On Tuesday, DVA shares rose 0.76 percent to trade at $109.11.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageChart Says This Retailer's Comeback Isn't Finished

One of the surprises, at least on the surface, of the market's recent swoon was the outperformance of read on...

article imageETF Performance Review: Major Asset Classes | 19 Dec 2014

It’s all about real estate investment trusts (REITs) these days when it comes to bullish performance among read on...

article imageOil and Global Stock Markets Rebounding Sharply

So far so good on our expectation of a 4 to 5% pullback and then a resumption of the bull read on...

article imageGrading the FOMC

Love its members or loathe them, you have to admire the gradual impact the policy-making committee has had read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.